US STOCKS-Futures ease as Sino-U.S. tensions heat up, fiscal deal awaited
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)
* Futures down: Dow 0.39%, S&P 500 0.39%, Nasdaq 0.05%
By Shriya Ramakrishnan
Dec 7 (Reuters) - U.S. stock index futures pulled back from record levels on Monday as fresh Sino-U.S. tensions over Hong Kong dented sentiment, while investors also awaited concrete signs of progress on a coronavirus relief bill.
Risk aversion hit global markets after Reuters reported Washington was preparing to impose sanctions on some Chinese officials over their alleged role in Beijing's disqualification of elected opposition legislators in Hong Kong. said it firmly opposed U.S. interference in its domestic affairs, in response to the report.
Meanwhile, talks aimed at delivering fresh coronavirus aid gathered momentum in the U.S. Congress on Friday, as a bipartisan group of lawmakers worked to put the finishing touches on a new $908 billion bill. months of deadlocked negotiations between Republicans and Democrats, pressure has mounted on policymakers to help people and businesses hit hard by the surging pandemic, especially after a set of weak labor market indicators.
The two parties also face a Dec. 11 deadline to approve an omnibus spending bill to prevent a government shutdown.
Shares of major U.S. banks including Morgan Stanley (NYSE: MS ) MS.N , Wells Fargo (NYSE: WFC ) & Co WFC.N , JPMorgan (NYSE: JPM ) & Chase Co JPM.N , Citigroup Inc (NYSE: C ) C.N and Goldman Sachs Group Inc (NYSE: GS ) GS.N fell between 0.4% and 1% in premarket trading.
Promising vaccine updates from major drugmakers has however raised investor hopes for an economic recovery next year and overshadowed worries over a surge in U.S. infections, powering Wall Street's main indexes to record highs recently.
At 6:31 a.m. ET, Dow e-minis 1YMcv1 were down 118 points, or 0.39%, S&P 500 e-minis EScv1 were down 14.25 points, or 0.39%, and Nasdaq 100 e-minis NQcv1 were down 6.5 points, or 0.05%.
Pfizer Inc (NYSE: PFE ) PFE.N rose 0.4% after a top Indian government health adviser said the drugmaker applied for emergency use authorization of its COVID-19 vaccine in the country. U.S. health advisory panel also meets on Thursday to discuss whether to recommend emergency use authorization of a the vaccine developed by Pfizer with German partner BioNTech SE 22UAy.DE .
Cisco Systems Inc CSCO.O edged 0.5% lower after the company agreed to buy London-based cloud communications software company IMImobile IMOI.L in a deal valued at about $730 million, including debt.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.
Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or